Skip to Main Content

Paper Details

Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone.
Eur Urol
35
2019
Author NameAffiliation
Eleni EfstathiouDavid H. Koch Center for Applied Research of GU Cancers, The University of Texas MD Anderson Cancer Center, University of Athens
  • 1 - 1

Datasets

Release 1.2